alpha-synuclein aggregation modulators (Prosetta Biosciences/Univ Duesseldorf)

N/A

Report date: 2025/03/14 16:20:35
NME

Base Information

Drug Namealpha-synuclein aggregation modulators (Prosetta Biosciences/Univ Duesseldorf)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSynuclein alpha inhibitors
TargetsSynuclein alpha
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProsetta Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesHeinrich Heine University DusseldorfProsetta Biosciences Inc
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A